Prostate cancerQuestions to ask your doctor
A cancer that starts in the prostate gland. Risk group, stage, and your goals for quality of life shape whether active surveillance or treatment is recommended.
Preview — not yet published
This page is in editorial and medical review. Content below is a scaffold — treat it as a preview, not guidance.
Practical prompts to bring to your next appointment — not a script, a starting point.
What is my risk group or grade group, and what does it mean?
Risk grouping helps compare active surveillance with surgery, radiation, or systemic therapy.
Has the cancer spread beyond the prostate on imaging or biopsy?
Am I a candidate for active surveillance, or is treatment recommended now?
What are the main side effects of each treatment option I should plan for?
Should I have genomic or biomarker testing on my tumor?
Are there clinical trials that fit my stage and risk group?
A note on using this list
Bring the 3–5 questions that matter most to you, not all of them. It’s also fine to take notes during the appointment, or bring someone with you who can.
Review, sources, and disclaimer
How this page was reviewed
Pending medical review. This page will list the reviewing clinician and review date before publication.
Sources will be listed here before publication. We prefer guideline-level and patient-trusted references.
This page is educational, not medical advice. Talk with your care team about decisions that apply to you. If something feels urgent, contact your doctor — or, for emergencies, call your local emergency number.